364 related articles for article (PubMed ID: 34172950)
1. Global epidemiology of valvular heart disease.
Coffey S; Roberts-Thomson R; Brown A; Carapetis J; Chen M; Enriquez-Sarano M; Zühlke L; Prendergast BD
Nat Rev Cardiol; 2021 Dec; 18(12):853-864. PubMed ID: 34172950
[TBL] [Abstract][Full Text] [Related]
2. Global, regional, and national incidence, mortality, and disability-adjusted life years of non-rheumatic valvular heart disease and trend analysis from 1990 to 2019: Results from the Global Burden of Disease study 2019.
Wang K; Geng B; Shen Q; Wang Y; Shi J; Dong N
Asian Cardiovasc Thorac Ann; 2023 Oct; 31(8):706-722. PubMed ID: 37674443
[TBL] [Abstract][Full Text] [Related]
3. Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades.
Coffey S; Cox B; Williams MJ
Am Heart J; 2014 Apr; 167(4):562-567.e2. PubMed ID: 24655706
[TBL] [Abstract][Full Text] [Related]
4. Trends and Disparities in Valvular Heart Disease Mortality in the United States From 1999 to 2020.
Tan MC; Yeo YH; San BJ; Suleiman A; Lee JZ; Chatterjee A; Sell-Dottin KA; Sweeney JP; Fortuin FD; Lee KS
J Am Heart Assoc; 2024 Apr; 13(8):e030895. PubMed ID: 38587138
[TBL] [Abstract][Full Text] [Related]
5. Current status and etiology of valvular heart disease in China: a population-based survey.
Yang Y; Wang Z; Chen Z; Wang X; Zhang L; Li S; Zheng C; Kang Y; Jiang L; Zhu Z; Gao R
BMC Cardiovasc Disord; 2021 Jul; 21(1):339. PubMed ID: 34256700
[TBL] [Abstract][Full Text] [Related]
6. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
Yadgir S; Johnson CO; Aboyans V; Adebayo OM; Adedoyin RA; Afarideh M; Alahdab F; Alashi A; Alipour V; Arabloo J; Azari S; Barthelemy CM; Benziger CP; Berman AE; Bijani A; Carrero JJ; Carvalho F; Daryani A; Durães AR; Esteghamati A; Farid TA; Farzadfar F; Fernandes E; Filip I; Gad MM; Hamidi S; Hay SI; Ilesanmi OS; Naghibi Irvani SS; Jürisson M; Kasaeian A; Kengne AP; Khan AR; Kisa A; Kisa S; Kolte D; Manafi N; Manafi A; Mensah GA; Mirrakhimov EM; Mohammad Y; Mokdad AH; Negoi RI; Thi Nguyen HL; Nguyen TH; Nixon MR; Otto CM; Patel S; Pilgrim T; Radfar A; Rawaf DL; Rawaf S; Rawasia WF; Rezapour A; Roever L; Saad AM; Saadatagah S; Senthilkumaran S; Sliwa K; Tesfay BE; Tran BX; Ullah I; Vaduganathan M; Vasankari TJ; Wolfe CDA; Yonemoto N; Roth GA;
Circulation; 2020 May; 141(21):1670-1680. PubMed ID: 32223336
[TBL] [Abstract][Full Text] [Related]
7. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
[TBL] [Abstract][Full Text] [Related]
8. Valvular Heart Disease Epidemics.
Domenech B; Pomar JL; Prat-González S; Vidal B; López-Soto A; Castella M; Sitges M
J Heart Valve Dis; 2016 Jan; 25(1):1-7. PubMed ID: 29505225
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
[TBL] [Abstract][Full Text] [Related]
10. Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank.
Tung M; Nah G; Tang J; Marcus G; Delling FN
Open Heart; 2022 Sep; 9(2):. PubMed ID: 36104095
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of acquired valvular heart disease.
Iung B; Vahanian A
Can J Cardiol; 2014 Sep; 30(9):962-70. PubMed ID: 24986049
[TBL] [Abstract][Full Text] [Related]
12. Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: a single center experience.
Manjunath CN; Srinivas P; Ravindranath KS; Dhanalakshmi C
Indian Heart J; 2014; 66(3):320-6. PubMed ID: 24973838
[TBL] [Abstract][Full Text] [Related]
13. Distribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in China: China-DVD Study.
Xu H; Liu Q; Cao K; Ye Y; Zhang B; Li Z; Hao J; Qi X; Zhao Q; Liu S; Gao R; Wu Y;
JACC Asia; 2022 Jun; 2(3):354-365. PubMed ID: 36338396
[TBL] [Abstract][Full Text] [Related]
14. The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older.
Rezzoug N; Vaes B; de Meester C; Degryse J; Van Pottelbergh G; Mathei C; Adriaensen W; Pasquet A; Vanoverschelde JL
BMC Cardiovasc Disord; 2016 Jan; 16():7. PubMed ID: 26754575
[TBL] [Abstract][Full Text] [Related]
15. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of valvular heart disease in the adult.
Iung B; Vahanian A
Nat Rev Cardiol; 2011 Mar; 8(3):162-72. PubMed ID: 21263455
[TBL] [Abstract][Full Text] [Related]
17. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study.
Huang X; Dhruva SS; Yuan X; Bai X; Lu Y; Yan X; Liu J; Li W; Hu D; Ji R; Gao M; Miao F; Li J; Ge J; Krumholz HM; Li J
BMJ Open; 2021 Nov; 11(11):e052946. PubMed ID: 34732492
[TBL] [Abstract][Full Text] [Related]
18. Valvular heart disease in Japan: Characteristics and treatment of patients in acute care hospitals in 2019.
Izumi C; Matsuyama R; Asaoka M; Iwasaki K; Takeshima T; Murphy S; Teng L; Igarashi A
J Cardiol; 2023 Jul; 82(1):29-34. PubMed ID: 36963659
[TBL] [Abstract][Full Text] [Related]
19. Profiles of hospitalized patients with valvular heart disease: Experience of a tertiary center.
Esteves AF; Brito D; Rigueira J; Ricardo I; Pires R; Pedro MM; Veiga F; Pinto F
Rev Port Cardiol (Engl Ed); 2018 Dec; 37(12):991-998. PubMed ID: 30554887
[TBL] [Abstract][Full Text] [Related]
20. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China.
Liu FZ; Xue YM; Liao HT; Zhan XZ; Guo HM; Huang HL; Fang XH; Wei W; Rao F; Deng H; Liu Y; Lin WD; Wu SL
J Thorac Dis; 2014 Dec; 6(12):1724-30. PubMed ID: 25589965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
